The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
Open accessAbstract
Peroxisome proliferator-activated receptors (PPARs) alpha and gamma are key regulators of lipid homeostasis and are activated by a structurally diverse group of compounds including fatty acids, eicosanoids, and hypolipidemic drugs such as fibrates and thiazolidinediones. While thiazolidinediones and 15-deoxy-Delta12, 14-prostaglandin J2 have been shown to bind to PPARgamma, it has remained unclear whether other activators mediate their effects through direct interactions with the PPARs or via indirect mechanisms. Here, we describe a novel fibrate, designated GW2331, that is a high-affinity ligand for both PPARalpha and PPARgamma. Using GW2331 as a radioligand in competition binding assays, we show that certain mono- and polyunsaturated fatty acids bind directly to PPARalpha and PPARgamma at physiological concentrations, and that the eicosanoids 8(S)-hydroxyeicosatetraenoic acid and 15-deoxy-Delta12,14-prostaglandin J2 can function as subtype-selective ligands for PPARalpha and PPARgamma, respectively. These data provide evidence that PPARs serve as physiological sensors of lipid levels and suggest a molecular mechanism whereby dietary fatty acids can modulate lipid homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PPARs are nuclear hormone receptors that respond to binding of endogenous fatty acids and fatty acid derivatives such as eicosanoids, by regulating expression of genes within diverse cellular pathways including lipid metabolism and inflammation (Kliewer et al., 1997; Chinetti et al., 2000).”
From The cell biology of the retinal pigment epithelium (2020) · cites this paper as Kliewer et al., 1997
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,564
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
FORMAN, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,857
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Preprint
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Lee, S. S. T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernández‐Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,652
Kliewer, S. A., FORMAN, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,402
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G. D., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,393
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- A L Catapano Pharmacol Rev 26, 331–340 (1992).
Cited by
Sorted by citations
Items 501–600 of 1,002
Nanji, A. A., Dannenberg, A. J., Jokelainen, K., & Bass, N. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064717 · Cited by 107
Savas, Ü., Griffin, K. J., & Johnson, E. F. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.851 · Cited by 106
Yang, H.-T., Chen, J.-W., Rathod, J., Jiang, Y.-Z., Tsai, P.-J., Hung, Y.-P., Ko, W.-C., Paredes-Sabja, D., & Huang, I.-H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02635 · Cited by 117
Boelsterli, U. A., & Bedoucha, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00817-6 · Cited by 103
Hunt, M. C., Nousiainen, S. E. B., Huttunen, M., Orii, K. E., Svensson, T., & Alexson, S. E. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34317 · Cited by 106
Expression of PPAR and RXR Isoforms in the Developing Rat and Human Term Placentas
Wang, Q., Fujii, H., & Knipp, G. T. (2002) · Placenta · doi:10.1053/plac.2002.0855 · Cited by 108
Mae, T., Kitahara, M., Nishiyama, T., Tsukagawa, M., Konishi, E., Kishida, H., Kuroda, M., Mimaki, Y., Sashida, Y., Takahashi, K., et al. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3369 · Cited by 105
Pontsler, A. V., Hilaire, A. S., Marathe, G. K., Zimmerman, G. A., & McIntyre, T. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109546200 · Cited by 105
A Tailored Therapy for the Metabolic Syndrome
Etgen, G. J., Oldham, B. A., Johnson, W. T., Broderick, C. L., Montrose, C., Brozinick, J. T., Misener, E. A., Bean, J. S., Bensch, W. R., Brooks, D. A., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1083 · Cited by 104
Xie, S., Lee, Y.-F., Kim, E., Chen, L.-M., Ni, J., Fang, L., Liu, S., Lin, S.-J., Abe, J., Berk, B. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905724106 · Cited by 104
The biochemistry of oleate induction: Transcriptional upregulation and peroxisome proliferation
Gurvitz, A., & Rottensteiner, H. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.07.011 · Cited by 111
PPARs and the kidney in metabolic syndrome
Ruan, X. Z., Zheng, F., & Guan, Y. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00152.2007 · Cited by 103
Transcriptional Regulation of the Mouse Uncoupling Protein-2 Gene
Medvedev, A. V., Snedden, S. K., Raimbault, S., Ricquier, D., & Collins, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010587200 · Cited by 101
Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milkPreprint
Wan, Y., Saghatelian, A., Chong, L.-W., Zhang, C.-L., Cravatt, B. F., & Evans, R. M. (2007) · Genes & Development · doi:10.1101/gad.1567207 · Cited by 104
Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages
Im, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.094 · Cited by 104
Role of Peroxisome Proliferator‐Activated Receptors in Inflammation Control
Youssef, J., & Badr, M. Z. (2004) · BioMed Research International · doi:10.1155/s1110724304308065 · Cited by 105
Glucose-Induced Preproinsulin Gene Expression Is Inhibited by the Free Fatty Acid Palmitate
Ritz-Laser, B., Meda, P., Constant, I., Klages, N., Charollais, A., Morales, A., Magnan, C., Ktorza, A., & Philippé, J. (1999) · Endocrinology · doi:10.1210/endo.140.9.6953 · Cited by 114
Moulson, C. L., Martin, D. R., Lugus, J. J., Schaffer, J. E., Lind, A. C., & Miner, J. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0431186100 · Cited by 103
Dietary modulation of peroxisome proliferator-activated receptor gamma
Marion‐Letellier, R., Déchelotte, P., Iacucci, M., & Ghosh, S. K. (2008) · Gut · doi:10.1136/gut.2008.162859 · Cited by 103
Stahl, A., Sapieha, P. S., Connor, K. M., SanGiovanni, J. P., Chen, J., Aderman, C. M., Willett, K. L., Krah, N. M., Dennison, R. J., Seaward, M. R., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.221317 · Cited by 104
Hunt, M. C., Rautanen, A., Westin, M. A. K., Svensson, T., & Alexson, S. E. H. (2006) · The FASEB Journal · doi:10.1096/fj.06-6042com · Cited by 102
A modified high-fat diet induces insulin resistance in rat skeletal muscle but not adipocytes
Wilkes, J. J., Bonen, A., & Bell, R. C. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e679 · Cited by 102
L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γ
Elbrecht, A., Chen, Y., Adams, A., Berger, J. P., Griffin, P. R., Klatt, T., Zhang, B., Menke, J. G., Zhou, G., Smith, R. G., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7913 · Cited by 102
Yoshimura, R., Matsuyama, M., Segawa, Y., Hase, T., Mitsuhashi, M., Tsuchida, K., Wada, S., Kawahito, Y., Sano, H., & Nakatani, T. (2003) · International Journal of Cancer · doi:10.1002/ijc.10980 · Cited by 104
Metabolic host response and therapeutic approaches to influenza infection
Keshavarz, M., Solaymani‐Mohammadi, F., Namdari, H., Arjeini, Y., Mousavi, M. J., & Rezaei, F. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00211-2 · Cited by 102
Hostetler, H. A., Kier, A. B., & Schroeder, F. (2006) · Biochemistry · doi:10.1021/bi060198l · Cited by 100
Is Iodine A Gatekeeper of the Integrity of the Mammary Gland?
Aceves, C., Anguiano, B., & Delgado, G. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-5401-5 · Cited by 100
Gardner, O., Dewar, B. J., & Graves, L. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012260 · Cited by 99
Bionaz, M., Thering, B. J., & Loor, J. J. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511002777 · Cited by 100
Yu, G.-S., Lu, Y., & Gulick, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32901 · Cited by 100
Boudreau, M. D., Sohn, K. H., Rhee, S. H., Lee, S. W., Hunt, J. D., & Hwang, D. H. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-2362 · Cited by 99
Lu, I.-L., Huang, C.-F., Peng, Y., Lin, Y., Hsieh, H., Chen, C., Lien, T., Lee, H., Mahindroo, N., Prakash, E., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051129s · Cited by 99
Palou, M., Priego, T., Sánchez, J., Villegas, E., Rodríguez, A. M., Palou, A., & Picó, C. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0461-1 · Cited by 103
Kasim-Karakas, S. E., Almario, R. U., Gregory, L., Wong, R., Todd, H., & Lasley, B. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030666 · Cited by 99
Montanari, R., Saccoccia, F., Scotti, E., Crestani, M., Godio, C., Gilardi, F., Loiodice, F., Fracchiolla, G., Laghezza, A., Tortorella, P., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800733h · Cited by 100
The pleiotropic function of PPARγ in the placenta
Schaiff, W. T., Barak, Y., & Sadovsky, Y. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.02.009 · Cited by 109
Wang, X., Reape, T. J., Li, X., Rayner, K., Webb, C. L., Burnand, K. G., & Lysko, P. G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01521-5 · Cited by 99
Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators
Corton, J. C., Lapinskas, P. J., & Gonzalez, F. J. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00232-8 · Cited by 99
Akiyama, T. E., Lambert, G., Nicol, C. J., Matsusue, K., Peters, J. M., Brewer, H. B., & Gonzalez, F. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312802200 · Cited by 97
Zhang, W., Xu, Y.-Z., Liu, B., Wu, R., Yang, Y., Xiao, X., & Zhang, X. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/603409 · Cited by 98
Obesity: molecular bases of a multifactorial problem
Palou, A., Serra, F. A., Bonet, M. L., & Picó, C. (2000) · European Journal of Nutrition · doi:10.1007/s003940070017 · Cited by 99
Shan, W., Palkar, P. S., Murray, I. A., McDevitt, E. I., Kennett, M. J., Kang, B. H., Isom, H. C., Perdew, G. H., Gonzalez, F. J., & Peters, J. M. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn142 · Cited by 97
Yu, S., Levi, L., Casadesús, G., Kunos, G., & Noy, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559062 · Cited by 97
Lu, Y., Feskens, E. J. M., Dollé, M. E. T., Imholz, S., Verschuren, W. M. M., Müller, M. M., & Boer, J. M. A. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29130 · Cited by 98
Bergouignan, A., Momken, I., Schoeller, D. A., Simon, C., & Blanc, S. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.02.004 · Cited by 99
Allen, T. L., Zhang, F., Moodie, S. A., Clemens, L. E., Smith, A. G., Gregoire, F. M., Bell, A., Muscat, G. E. O., & Gustafson, T. A. (2006) · Diabetes · doi:10.2337/db06-0618 · Cited by 97
Brocker, C. N., Yue, J., Kim, D., Qu, A., Bonzo, J. A., & Gonzalez, F. J. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00205.2016 · Cited by 93
Thakur, J. K., Arthanari, H., Yang, F., Chau, K. H., Wagner, G., & Näär, A. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808263200 · Cited by 96
Dooper, M. M. B. W., Wassink, L., M’Rabet, L., & Graus, Y. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01474.x · Cited by 96
Meirhaeghe, A., Fajas, L., Gouilleux, F., Cottel, D., Helbecque, N., Auwerx, J. H., & Amouyel, P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000051382.28752.fe · Cited by 93
Nuclear receptors as drug targets for metabolic disease
Schulman, I. G. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.002 · Cited by 95
Nuclear receptors in neurodegenerative diseases
Skerrett, R., Malm, T., & Landreth, G. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.019 · Cited by 94
Polycyclic aromatic hydrocarbons stimulate human CYP3A4 promoter activity via PXR
Luckert, C., Ehlers, A., Buhrke, T., Seidel, A., Lampen, A., & Hessel‐Pras, S. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.06.243 · Cited by 95
Ajmone‐Cat, M. A., Salvatori, M. L., Simone, R. D., Mancini, M., Biagioni, S., Bernardo, A., Cacci, E., & Minghetti, L. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22783 · Cited by 99
Floyd, Z. E., Wang, Z. Q., Kilroy, G. E., & Cefalu, W. T. (2008) · Metabolism · doi:10.1016/j.metabol.2008.04.006 · Cited by 95
Takeuchi, S., Matsuda, T., Kobayashi, S., Takahashi, T., & Kojima, H. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.08.011 · Cited by 100
Asatryan, A., & Bazan, N. G. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.783076 · Cited by 99
Pathogenesis of Alcoholic Liver Disease. Newer Mechanisms of Injury.
Crabb, D. W. (1999) · The Keio Journal of Medicine · doi:10.2302/kjm.48.184 · Cited by 95
Meital, L. T., Windsor, M., Perissiou, M., Schulze, K., Magee, R., Kuballa, A., Golledge, J., Bailey, T. G., Askew, C. D., & Russell, F. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-49362-z · Cited by 94
Reduction of Circulating Cholesterol and Apolipoprotein Levels during Sepsis
Fraunberger, P., Schaefer, S., Werdan, K., Walli, A. K., & Seidel, D. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.059 · Cited by 94
Marks, F., Müller‐Decker, K., & Fürstenberger, G. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00301-2 · Cited by 95
Son, C., Hosoda, K., Matsuda, J., Fujikura, J., Yonemitsu, S., Iwakura, H., Masuzaki, H., Ogawa, Y., Hayashi, T., Itoh, H., et al. (2001) · Endocrinology · doi:10.1210/endo.142.10.8446 · Cited by 95
Allosteric inhibition of a stem cell RNA-binding protein by an intermediary metabolite
Clingman, C. C., Deveau, L. M., Hay, S. A., Genga, R. M. J., Shandilya, S. M. D., Massi, F., & Ryder, S. (2014) · eLife · doi:10.7554/elife.02848 · Cited by 92
Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats
Hussein, O. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i3.361 · Cited by 93
Kuroda, M., Mimaki, Y., Sashida, Y., Mae, T., Kishida, H., Nishiyama, T., Tsukagawa, M., Konishi, E., Takahashi, K., Kawada, T., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.052 · Cited by 93
Thomas, M., Burk, O., Klumpp, B., Kandel, B. A., Damm, G., Weiß, T. S., Klein, K., Schwab, M. G., & Zanger, U. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.082503 · Cited by 92
PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism
van Diepen, J. A., Jansen, P. A. M., Ballak, D. B., Hijmans, A., Hooiveld, G. J. E. J., Rommelaere, S., Galland, F., Naquet, P., Rutjes, F. P. J. T., Mensink, R. P., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.013 · Cited by 92
Ursolic acid is a PPAR-α agonist that regulates hepatic lipid metabolism
Jia, Y., Bhuiyan, M. J. H., Jun, H., Lee, J. H., Hoang, M. H., Lee, H.-J., Kim, N., Lee, D., Hwang, K. Y., Hwang, B. Y., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.095 · Cited by 92
Berger, A., Mutch, D. M., German, J. B., & Roberts, M. (2002) · Lipids in Health and Disease · doi:10.1186/1476-511x-1-2 · Cited by 90
The Activity of PPARγ in Primary Human Trophoblasts Is Enhanced by Oxidized Lipids
Schild, R. L., Schaiff, W. T., Carlson, M. G., Cronbach, E. J., Nelson, D. M., & Sadovsky, Y. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8284 · Cited by 93
Majdalawieh, A. F., & Ro, H.-S. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08004 · Cited by 94
The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity
Celi, F. S., & Shuldiner, A. R. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0078-2 · Cited by 91
Martin, F., Wang, Y., Sprenger, N., Yap, I. K. S., Rezzi, S., Ramadan, Z., Peré‐Trepat, E., Rochat, F., Cherbut, C., van Bladeren, P., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.40 · Cited by 90
Molecular Mechanisms of Adipocyte Differentiation
Tong, Q., & Hotamışlıgil, G. S. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1011863414321 · Cited by 91
Couturier, C., Brouillet, A., Couriaud, C., Koumanov, K. S., Bereziat, G., & Andréani, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23085 · Cited by 91
Brocker, C. N., Kim, D., Melia, T., Karri, K., Velenosi, T. J., Takahashi, S., Aibara, D., Bonzo, J. A., Levi, M., Waxman, D. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19554-7 · Cited by 88
Membrane lipid alterations in the metabolic syndrome and the role of dietary oils
Perona, J. S. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.04.015 · Cited by 91
Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ
Shang, J., Brust, R., Mosure, S. A., Bass, J., Munoz‐Tello, P., Lin, H., Hughes, T., Tang, M., Ge, Q., Kamenekca, T. M., et al. (2018) · eLife · doi:10.7554/elife.43320 · Cited by 95
Andersen, Ø., Eijsink, V. G. H., & Thomassen, M. S. (2000) · Gene · doi:10.1016/s0378-1119(00)00350-4 · Cited by 89
The role of the endocannabinoid system in lipogenesis and fatty acid metabolism
Vettor, R., & Pagano, C. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.002 · Cited by 90
Soares, M. J., Cummings, S. J., Mamo, J. C. L., Kenrick, M., & Piers, L. S. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20031047 · Cited by 89
Peroxisome proliferator activated receptor agonists
Kersten, S., & Wahli, W. (2000) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-8393-1_9 · Cited by 89
Hao, C., Kömhoff, M., Guan, Y., Redha, R., & Breyer, M. D. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.3.f352 · Cited by 89
Metabolism and functions of highly unsaturated fatty acids: An update
Nakamura, M., Cho, H. P., Xu, J., Tang, Z., & Clarke, S. D. (2001) · Lipids · doi:10.1007/s11745-001-0806-5 · Cited by 92
Rumi, M. A. K., Sato, H., Ishihara, S., Kawashima, K., Hamamoto, S., Kazumori, H., Okuyama, T., Fukuda, R., Nagasue, N., & Kinoshita, Y. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1821 · Cited by 88
Kim, Y., Hirai, S., Takahashi, H., Goto, T., Ohyane, C., Tsugane, T., Konishi, C., Fujii, T., Inai, S., Iijima, Y., et al. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000264 · Cited by 88
Dupont, J., Scaramuzzi, R. J., & Reverchon, M. (2014) · animal · doi:10.1017/s1751731114000937 · Cited by 88
Latini, G., Scoditti, E., Verrotti, A., Felice, C. D., & Massaro, M. (2007) · PPAR Research · doi:10.1155/2008/359267 · Cited by 93
Plutzky, J. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0067-3 · Cited by 87
Matsuura, H., Adachi, H., Smart, R. C., Xu, X., Arata, J., & Jetten, A. M. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00214-7 · Cited by 89
Bezafibrate is a dual ligand for PPARα and PPARβ: studies using null mice
Peters, J. M., Aoyama, T., Burns, A., & Gonzalez, F. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00065-9 · Cited by 92
Lindi, V., Schwab, U., Louheranta, A. M., Laakso, M., Vessby, B. O., Hermansen, K., Storlien, L. H., Riccardi, G., & Rivellese, A. A. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00065-9 · Cited by 86
Activation of the orphan receptor RIP14 by retinoids
Zavacki, A. M., Lehmann, J. M., Seol, W., Willson, T. M., Kliewer, S. A., & Moore, D. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7909 · Cited by 87
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
Ercolano, G., Gomez‐Cadena, A., Dumauthioz, N., Vanoni, G., Kreutzfeldt, M., Wyss, T., Michalik, L., Loyon, R., Ianaro, A., Ho, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22764-2 · Cited by 87
Lipid sensing and lipid sensors
Grimaldi, P. A. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7278-5 · Cited by 89
Genes, Diet and Type 2 Diabetes Mellitus: A Review
Dedoussis, G. V., Kaliora, A. C., & Panagiotakos, D. B. (2007) · The Review of Diabetic Studies · doi:10.1900/rds.2007.4.13 · Cited by 91
Li, Q., Cheon, Y., Kannan, A., Shanker, S., Bagchi, I. C., & Bagchi, M. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311773200 · Cited by 86
Serum lipids regulate dendritic cell CD1 expression and function
Leslie, D. S., Dascher, C. C., Cembrola, K., Townes, M. A., Hava, D. L., Hugendubler, L., Mueller, E., Fox, L. M., Roura‐Mir, C., Moody, D. B., et al. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02842.x · Cited by 86
Lipid concentrations and semen quality: the LIFE study
Schisterman, E. F., Mumford, S. L., Chen, Z., Browne, R. W., Barr, D. B., Kim, S., & Louis, G. M. B. (2014) · Andrology · doi:10.1111/j.2047-2927.2014.00198.x · Cited by 90
Digging deep into the pockets of orphan nuclear receptors: insights from structural studies
Benoit, G., Malewicz, M., & Perlmann, T. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.05.007 · Cited by 86
Metadata
- Authors
- Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., & Lehmann, J. M.
- Affiliations
- University of Lausanne (CH)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1997-04-29
- Volume
- 94
- Issue
- 9
- Pages
- 4318-4323
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC20720
- OpenAlex
- W2139002144
- Cited by
- 2,164
- References
- 41
- Citations by year
- 2026: 33 · 2025: 37 · 2024: 47 · 2023: 34 · 2022: 47 · 2021: 62 · 2020: 54 · 2019: 59 · 2018: 59 · 2017: 56 · 2016: 49 · 2015: 76 · 2014: 76 · 2013: 61 · 2012: 64
- FWCI
- 35.08
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- peroxisome proliferator-activated receptors, PPARα, PPARγ, fatty acids, eicosanoids, fibrates, thiazolidinediones, 15-deoxy-Δ12,14-prostaglandin J2, ligand binding, lipid homeostasis, gene expression regulation, dietary fatty acids
- MeSH terms
- Animals, Hypolipidemic Agents, Binding, Competitive, Butyrates, Fatty Acids, Gene Expression Regulation, Humans, Ligands, Phenylurea Compounds, Recombinant Fusion Proteins, Species Specificity, Transcription Factors, Xenopus, Eicosanoids, Receptors, Cytoplasmic and Nuclear, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review